Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALB vs GSK✓SelectedUSD · GSKALB vs GSK performance historyLatest closeAs of-0.56%11/17
Stock and ETF performance explorer

ALB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+20.7%
GSK return
+104.0%
Excess return
-83.3%
Maximum drawdown
-83.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.6%-2.3%+1.8%+0.3%
7D-7.6%-3.0%-4.6%-6.6%
30D-8.2%+0.4%-8.5%-8.4%
3M-34.3%-1.2%-33.2%-34.3%
6M-51.1%+0.9%-52.0%-51.7%
YTD-37.5%+4.0%-41.5%-39.3%
1Y-24.7%+7.3%-32.0%-27.8%
3Y-27.9%+57.1%-84.9%-42.8%
5Y-65.9%+43.0%-108.9%-72.5%
10Y+20.7%+103.1%-82.4%-15.1%
All+20.7%+104.0%-83.3%-15.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling